Peptide receptor radionuclide therapy for sarcoidosis

to connected objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: American Journal of Respiratory and Critical Care Medicine, 194, 11, S. 1428-1430

Event: Veröffentlichung

(where): Augsburg

(who): Universität Augsburg

(when): 2016

Event: Veröffentlichung

(where): New York, NY

(who): American Thoracic Society

(when): 2016

Creator: Lapa, Constantin Frederik Victor
Grigoleit, Götz Ulrich
Hänscheid, Heribert
Klinker, Erdwine
Jung, Pius
Herrmann, Ken
Schirbel, Andreas
Böck, Markus
Buck, Andreas K.
Pelzer, Theo

DOI: 10.1164/rccm.201603-0579le

URN: urn:nbn:de:bvb:384-opus4-630916

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 25.03.2025, 1:49 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lapa, Constantin Frederik Victor
Grigoleit, Götz Ulrich
Hänscheid, Heribert
Klinker, Erdwine
Jung, Pius
Herrmann, Ken
Schirbel, Andreas
Böck, Markus
Buck, Andreas K.
Pelzer, Theo
Universität Augsburg
American Thoracic Society

Time of origin

2016

Other Objects (12)

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy

Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

$Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients$

Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients

DNA damage assay in blood lymphocytes in peptide receptor radionuclide therapy patients with personalised high activities [Abstract]

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

$Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma$

Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy

Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

$Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients$

Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients

DNA damage assay in blood lymphocytes in peptide receptor radionuclide therapy patients with personalised high activities [Abstract]

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

$Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma$

Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy

Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

$Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients$

Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients

DNA damage assay in blood lymphocytes in peptide receptor radionuclide therapy patients with personalised high activities [Abstract]

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

$Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma$

Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Peptide receptor radionuclide therapy for sarcoidosis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy

Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients

DNA damage assay in blood lymphocytes in peptide receptor radionuclide therapy patients with personalised high activities [Abstract]

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy

Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients

DNA damage assay in blood lymphocytes in peptide receptor radionuclide therapy patients with personalised high activities [Abstract]

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy

Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?

Pre-therapy Somatostatin-Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients

DNA damage assay in blood lymphocytes in peptide receptor radionuclide therapy patients with personalised high activities [Abstract]

Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma

Related objects

Reset password